HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy
2006 · Oncogene · 160 citations
https://doi.org/10.1038/sj.onc.1209685
W
Weiqun Mao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
72
Papers
1.2K
Citations
23
h-index
27
i10-index
Weiqun Mao is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer-related Molecular Pathways & Autophagy in Disease and Therapy & Microtubule and mitosis dynamics. The author has an h-index of 23, co-authored 62 publications.
Papers by this author
worksGenes Affecting the Cell Cycle, Growth, Maintenance, and Drug Sensitivity Are Preferentially Regulated by Anti-HER2 Antibody through Phosphatidylinositol 3-Kinase-AKT Signaling
2004 · Journal of Biological Chemistry · 71 citations
https://doi.org/10.1074/jbc.m403080200
Specific blockade of VEGF and HER2 pathways results in greater growth inhibition of breast cancer xenografts that overexpress HER2
2008 · Cell Cycle · 64 citations
https://doi.org/10.4161/cc.7.23.7212
ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts
2015 · Cell Death and Disease · 62 citations
https://doi.org/10.1038/cddis.2015.208
ATP directed agent, 8-chloro-adenosine, induces AMP activated protein kinase activity, leading to autophagic cell death in breast cancer cells
2014 · Journal of Hematology & Oncology · 36 citations
https://doi.org/10.1186/1756-8722-7-23
Induction of autophagy by ARHI (DIRAS3) alters fundamental metabolic pathways in ovarian cancer models
2016 · BMC Cancer · 27 citations
https://doi.org/10.1186/s12885-016-2850-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat